Pregled bibliografske jedinice broj: 1210955
Omicron: increased transmissibility and decreased pathogenicity
Omicron: increased transmissibility and decreased pathogenicity // Signal Transduction and Targeted Therapy, 7 (2022), 1; 151, 3 doi:10.1038/s41392-022-01009-8 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1210955 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Omicron: increased transmissibility and decreased
pathogenicity
Autori
Bálint, Gábor ; Vörös-Horváth, Barbara ; Széchenyi, Aleksandar
Izvornik
Signal Transduction and Targeted Therapy (2059-3635) 7
(2022), 1;
151, 3
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Omicron: increased transmissibility and decreased pathogenicity
Sažetak
Three research papers were published recently to compare the virological properties of the Omicron variant with the earlier variants of concern (VOC).1–3 The SARS-CoV-2 B.1.1.529 variant, Omicron, was first detected in South Africa in October 2021 and has spread rapidly ; within three months, it appeared in more than 87 countries.4 During the surveillance of the epidemiological data and mutations of earlier COVID-19 variants and Omicron, significant differences were revealed mainly in the reproduction rate and hospitalization. Although a modest severity can be observed in the case of Omicron, its 3, 31-fold higher transmissibility than Delta variant and increased resistance to antiviral immunity1 represents a global epidemic threat.
Izvorni jezik
Engleski
Znanstvena područja
Interdisciplinarne prirodne znanosti
Napomena
Research Highlight
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE